Back
Editas Medicine Vs. Strategy Industry Stock Comparison
Sell
1
EDIT
Editas Medicine
Last Price:
$1.27
Seasonality Move:
-10.13%
Buy
53
MSTR
Strategy
Last Price:
$297.13
Seasonality Move:
-4.18%
Sell
1
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.37. The Score for EDIT is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
MSTR Stock Price Chart
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 44.11 | Sell |
Chaikin Money Flow: | -164815 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.26 - 2.08) | Sell |
Bollinger Bands (100): | (1.21 - 2.59) | Sell |
MSTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.06 | Sell |
Relative Strength Index (14 RSI): | 52.34 | Buy |
Chaikin Money Flow: | 1261112 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (262.73 - 320.31) | Buy |
Bollinger Bands (100): | (272.3 - 382.2) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.41 | Sell |
20-day SMA: | 1.75 | Sell |
50-day SMA: | 1.49 | Sell |
200-day SMA: | 3.15 | Sell |
8-day EMA: | 0.3 | Buy |
20-day EMA: | 0.13 | Buy |
50-day EMA: | 0.05 | Buy |
200-day EMA: | 0.01 | Buy |
MSTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 283.46 | Buy |
20-day SMA: | 282.26 | Buy |
50-day SMA: | 320.31 | Sell |
200-day SMA: | 239.7 | Buy |
8-day EMA: | 290.58 | Buy |
20-day EMA: | 291.96 | Buy |
50-day EMA: | 307.11 | Sell |
200-day EMA: | 253.71 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Strategy Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.
Editas Medicine Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Strategy Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |